Abstract | PURPOSE: MATERIALS AND METHODS: This retrospective study was approved by the institutional review board and was HIPAA compliant; informed consent was not required. Charts and self-reported pain score evaluations were retrospectively reviewed in 114 patients (56 men, 58 women; age range, 36-84 years; mean age, 60 years) treated for radiculopathy from 1997 to 2003 with 130 selective lumbar nerve blocks with triamcinolone or betamethasone. Perineural location was confirmed with fluoroscopic guidance. Forty-nine patients received a mixture of 1 mL of the triamcinolone, 40 mg/mL, and 1 mL of 0.5% bupivacaine hydrochloride. Eighty-one patients received a mixture of 1 mL of the betamethasone, 6 mg/mL, and 1 mL of 0.5% bupivacaine hydrochloride. Patients completed standardized pain evaluation sheets and compared their pain with baseline levels during 14 days after injection. Fisher exact test was used for data analysis. RESULTS: CONCLUSION:
|
Authors | Donna G Blankenbaker, Arthur A De Smet, Jeffrey D Stanczak, Jason P Fine |
Journal | Radiology
(Radiology)
Vol. 237
Issue 2
Pg. 738-41
(Nov 2005)
ISSN: 0033-8419 [Print] United States |
PMID | 16192319
(Publication Type: Journal Article)
|
Chemical References |
- Anesthetics, Local
- Anti-Inflammatory Agents
- Suspensions
- Betamethasone
- Triamcinolone Acetonide
- Bupivacaine
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Anesthetics, Local
(therapeutic use)
- Anti-Inflammatory Agents
(therapeutic use)
- Betamethasone
(therapeutic use)
- Bupivacaine
(therapeutic use)
- Female
- Fluoroscopy
- Humans
- Injections
- Low Back Pain
(drug therapy)
- Lumbar Vertebrae
- Male
- Middle Aged
- Nerve Block
(methods)
- Pain Measurement
- Radiculopathy
(drug therapy)
- Radiography, Interventional
- Retrospective Studies
- Suspensions
- Treatment Outcome
- Triamcinolone Acetonide
(therapeutic use)
|